rectum_001:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "KRAS wild-type. NRAS wild-type. BRAF V600E negative. MSI stable by PCR. MLH1, MSH2, MSH6, PMS2 all retained on IHC."

rectum_002:
  morphology: ADENOCARCINOMA
  descriptive_name: Moderately differentiated rectal carcinoma
  biomarker_profile: "KRAS mutation detected in codon 12 (G12D). MSI-H identified. Loss of MLH1 and PMS2 expression."

rectum_003:
  morphology: NEUROENDOCRINE
  descriptive_name: Rectal neuroendocrine tumor
  biomarker_profile: "No targetable alterations identified."

rectum_004:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal cancer
  biomarker_profile: "RAS/RAF testing: KRAS G13D mutation present. MMR proficient."

rectum_005:
  morphology: ADENOCARCINOMA
  descriptive_name: Low rectal adenocarcinoma
  biomarker_profile: "Comprehensive genomic profiling revealed KRAS p.G12V, TP53 p.R248W, and HER2 amplification (copy number 12). TMB: 8.4 mut/Mb. MSS. PD-L1 CPS <1."

rectum_006:
  morphology: CARCINOID
  descriptive_name: Rectal carcinoid tumor
  biomarker_profile: "None tested."

rectum_007:
  morphology: ADENOCARCINOMA
  descriptive_name: Distal rectal adenocarcinoma
  biomarker_profile: "All RAS wild-type. BRAF WT. Microsatellite stable."

rectum_008:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenoca
  biomarker_profile: "NRAS mutation Q61K detected."

rectum_009:
  morphology: ADENOCARCINOMA
  descriptive_name: Poorly differentiated rectal carcinoma
  biomarker_profile: "MSI-high. Complete loss of MSH2/MSH6 staining suggestive of Lynch syndrome. KRAS/NRAS/BRAF all wild-type. TP53 p.R175H. TMB elevated at 42 mutations/Mb."

rectum_010:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectosigmoid junction adenocarcinoma
  biomarker_profile: "KRAS wt, NRAS wt, BRAF wt. MMR intact."

rectum_011:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma, intestinal type
  biomarker_profile: "Extended RAS testing identified KRAS G12C mutation. MSI-L. PD-L1 negative."

rectum_012:
  morphology: NEUROENDOCRINE
  descriptive_name: High-grade neuroendocrine carcinoma of rectum
  biomarker_profile: "No biomarker testing performed."

rectum_013:
  morphology: ADENOCARCINOMA
  descriptive_name: T3N1 rectal adenocarcinoma
  biomarker_profile: "RAS/RAF panel negative. Mismatch repair proteins intact. HER2 3+ by immunohistochemistry with HER2/CEP17 ratio 2.8 by FISH."

rectum_014:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal CA
  biomarker_profile: "BRAF V600E mutation detected. MSS."

rectum_015:
  morphology: ADENOCARCINOMA
  descriptive_name: Mucinous adenocarcinoma of rectum
  biomarker_profile: "KRAS mutation in exon 2. TP53 mutation. MMR proficient. TMB low."

rectum_016:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "Pan-RAS wild-type."

rectum_017:
  morphology: ADENOCARCINOMA
  descriptive_name: Invasive rectal adenocarcinoma
  biomarker_profile: "Next-generation sequencing: KRAS p.G12A, TP53 p.Y220C, ERBB2 amplification absent. MSI stable. TMB 3.2 mut/Mb."

rectum_018:
  morphology: CARCINOID
  descriptive_name: Well-differentiated rectal NET
  biomarker_profile: "No molecular testing indicated."

rectum_019:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal cancer, stage IIIB
  biomarker_profile: "KRAS G12V positive. NRAS negative. BRAF negative. MLH1 methylation absent. All MMR proteins expressed."

rectum_020:
  morphology: ADENOCARCINOMA
  descriptive_name: Lower rectal adenocarcinoma
  biomarker_profile: "MSI-H, dMMR with loss of MLH1/PMS2."

rectum_021:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "KRAS wild-type, NRAS wild-type, BRAF wild-type. Microsatellite stable. TP53 mutant (c.818G>A)."

rectum_022:
  morphology: ADENOCARCINOMA
  descriptive_name: Colorectal carcinoma
  biomarker_profile: "RAS mutations absent."

rectum_023:
  morphology: ADENOCARCINOMA
  descriptive_name: Moderately diff rectal adeno
  biomarker_profile: "KRAS exon 2 mutation (G13D). MMR intact by IHC. PD-L1 TPS 0%."

rectum_024:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma with signet ring features
  biomarker_profile: "Comprehensive panel: KRAS Q61H, BRAF wild-type, MSI-stable, HER2 negative (0 by IHC), TP53 R273C."

rectum_025:
  morphology: NEUROENDOCRINE
  descriptive_name: Rectal neuroendocrine neoplasm
  biomarker_profile: "Not tested."

rectum_026:
  morphology: ADENOCARCINOMA
  descriptive_name: Anorectal adenocarcinoma
  biomarker_profile: "NRAS codon 61 mutation detected. MSS by PCR-based assay."

rectum_027:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "All biomarkers negative: RAS/RAF WT, MSS, HER2 non-amplified, PD-L1 0%, TMB low."

rectum_028:
  morphology: ADENOCARCINOMA
  descriptive_name: Mid-rectal tumor
  biomarker_profile: "KRAS mutation present (G12D)."

rectum_029:
  morphology: ADENOCARCINOMA
  descriptive_name: Well-differentiated rectal adenocarcinoma
  biomarker_profile: "Microsatellite instability high. Germline testing revealed MSH2 pathogenic variant c.942+3A>T consistent with Lynch syndrome. KRAS/NRAS/BRAF triple wild-type."

rectum_030:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adeno
  biomarker_profile: "RAS wt, BRAF wt."

rectum_031:
  morphology: ADENOCARCINOMA
  descriptive_name: Invasive adenocarcinoma of rectosigmoid
  biomarker_profile: "KRAS p.G12S mutation. TP53 p.R282W. MSI-Low. TMB intermediate (7 mut/Mb)."

rectum_032:
  morphology: CARCINOID
  descriptive_name: Grade 1 rectal neuroendocrine tumor
  biomarker_profile: "None."

rectum_033:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal cancer
  biomarker_profile: "Extended molecular profiling: KRAS A146T, BRAF WT, PIK3CA E545K, TP53 splice site mutation. MMR proficient. ERBB2 not amplified."

rectum_034:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma, locally advanced
  biomarker_profile: "Wild-type for all RAS genes."

rectum_035:
  morphology: ADENOCARCINOMA
  descriptive_name: Distal rectal Ca
  biomarker_profile: "MSI-H with absent MSH6 staining. TMB high at 28 mut/Mb. PD-L1 CPS 15."

rectum_036:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "KRAS G12V."

rectum_037:
  morphology: ADENOCARCINOMA
  descriptive_name: Upper rectal adenocarcinoma
  biomarker_profile: "Molecular testing shows KRAS wild-type, NRAS wild-type, BRAF V600E negative. Mismatch repair proficient with intact expression of all four proteins."

rectum_038:
  morphology: NEUROENDOCRINE
  descriptive_name: Poorly differentiated NEC of rectum
  biomarker_profile: "No targetable mutations identified."

rectum_039:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma, stage IV
  biomarker_profile: "BRAF V600E mutant. MSS. HER2 2+ equivocal by IHC, FISH negative."

rectum_040:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal carcinoma
  biomarker_profile: "NGS panel: No actionable mutations detected. TMB 2 mut/Mb."

rectum_041:
  morphology: ADENOCARCINOMA
  descriptive_name: Low-lying rectal cancer
  biomarker_profile: "KRAS exon 3 mutation (Q61L). MMR proteins all retained."

rectum_042:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma with mucinous features
  biomarker_profile: "MSI testing indeterminate. IHC shows focal loss of MSH2."

rectum_043:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal AC
  biomarker_profile: "KRAS G13C mutation identified."

rectum_044:
  morphology: ADENOCARCINOMA
  descriptive_name: T4N2 rectal adenocarcinoma
  biomarker_profile: "Comprehensive genomic profiling: KRAS WT, NRAS WT, BRAF WT, MSI-stable, TP53 R248Q, APC truncating mutation. HER2 amplified (ratio 4.2). TMB 5.8 mutations/Mb."

rectum_045:
  morphology: CARCINOID
  descriptive_name: Rectal carcinoid
  biomarker_profile: "Biomarker testing not performed."

rectum_046:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "RAS/RAF triple negative. MSI-H."

rectum_047:
  morphology: ADENOCARCINOMA
  descriptive_name: Poorly differentiated rectal cancer
  biomarker_profile: "NRAS mutation detected in codon 13."

rectum_048:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma, intestinal type
  biomarker_profile: "All molecular markers negative. TMB low. PD-L1 negative."

rectum_049:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectosigmoid carcinoma
  biomarker_profile: "KRAS p.G12A, TP53 p.V157F. Microsatellite stable. MMR intact."

rectum_050:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal cancer
  biomarker_profile: "MSI-High."

rectum_051:
  morphology: ADENOCARCINOMA
  descriptive_name: Moderately differentiated rectal adenocarcinoma
  biomarker_profile: "Liquid biopsy detected KRAS G12D mutation at 2.3% VAF. Tissue confirmation pending."

rectum_052:
  morphology: NEUROENDOCRINE
  descriptive_name: Rectal NET G2
  biomarker_profile: "Not applicable."

rectum_053:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "KRAS wild-type. NRAS wild-type. BRAF wild-type. HER2/neu negative (1+ by IHC)."

rectum_054:
  morphology: ADENOCARCINOMA
  descriptive_name: Invasive rectal carcinoma
  biomarker_profile: "Extended RAS/RAF panel all wild-type. MSI-Low. PD-L1 TPS <1%. TMB 4 mut/Mb."

rectum_055:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adeno, mod diff
  biomarker_profile: "BRAF non-V600 mutation (D594G) detected. MSS."

rectum_056:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "KRAS mutation positive."

rectum_057:
  morphology: ADENOCARCINOMA
  descriptive_name: Distal rectal adenocarcinoma
  biomarker_profile: "Genomic analysis: KRAS p.G12C, TP53 loss of function, ERBB2 copy number normal. MSI-stable. TMB 6.2 mut/Mb."

rectum_058:
  morphology: CARCINOID
  descriptive_name: Well-differentiated rectal neuroendocrine tumor
  biomarker_profile: "No testing required."

rectum_059:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal cancer, post-neoadjuvant
  biomarker_profile: "KRAS/NRAS double wild-type. BRAF V600E negative. MLH1 promoter hypermethylation present with loss of MLH1/PMS2 expression."

rectum_060:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "Pan-wild-type for RAS/RAF/PIK3CA."

rectum_061:
  morphology: ADENOCARCINOMA
  descriptive_name: Upper third rectal tumor
  biomarker_profile: "KRAS mutation in exon 2 (G12V). MSI stable by pentaplex PCR."

rectum_062:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal carcinoma with signet cells
  biomarker_profile: "MSI-H/dMMR. Complete absence of MSH2 and MSH6 protein expression. Germline testing recommended."

rectum_063:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenoca
  biomarker_profile: "NRAS G12D detected."

rectum_064:
  morphology: ADENOCARCINOMA
  descriptive_name: Well to moderately differentiated rectal adenocarcinoma
  biomarker_profile: "Foundation One CDx: KRAS wild-type, NRAS wild-type, BRAF wild-type, TP53 p.Y234C, APC p.R1450*, MSI-stable, TMB-Low (2 mut/Mb), HER2 not amplified."

rectum_065:
  morphology: NEUROENDOCRINE
  descriptive_name: Mixed adenoneuroendocrine carcinoma of rectum
  biomarker_profile: "Limited testing performed. MSS."

rectum_066:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "KRAS codon 12 mutation."

rectum_067:
  morphology: ADENOCARCINOMA
  descriptive_name: Low rectal cancer
  biomarker_profile: "All RAS isoforms tested negative. BRAF V600E negative. Microsatellite stable with retained MMR protein expression."

rectum_068:
  morphology: ADENOCARCINOMA
  descriptive_name: Metastatic rectal adenocarcinoma
  biomarker_profile: "KRAS G13D mutation. HER2 amplification detected (IHC 3+, FISH positive with ratio 3.8)."

rectum_069:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal Ca, stage II
  biomarker_profile: "MSI-stable."

rectum_070:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "Molecular profiling reveals no targetable alterations. RAS/RAF wild-type, MSS, HER2 negative."

rectum_071:
  morphology: CARCINOID
  descriptive_name: Rectal neuroendocrine tumor, Grade 1
  biomarker_profile: "None indicated."

rectum_072:
  morphology: ADENOCARCINOMA
  descriptive_name: Invasive adenocarcinoma of the rectum
  biomarker_profile: "BRAF V600E mutation present. MSI-H with loss of MLH1. MLH1 promoter methylation positive."

rectum_073:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "KRAS wt."

rectum_074:
  morphology: ADENOCARCINOMA
  descriptive_name: Mid-rectal adenocarcinoma
  biomarker_profile: "Tempus xT assay: KRAS p.A146T, NRAS wild-type, BRAF wild-type, TP53 p.C242F, MSI-indeterminate, TMB 8 mut/Mb, PD-L1 CPS 3."

rectum_075:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal cancer
  biomarker_profile: "Extended RAS mutation detected (KRAS Q61H)."

rectum_076:
  morphology: ADENOCARCINOMA
  descriptive_name: Poorly differentiated rectal adenocarcinoma
  biomarker_profile: "Hypermutated tumor with TMB 156 mut/Mb. MSI-H. Loss of MSH6 protein. Multiple secondary mutations including KRAS, TP53, and PIK3CA."

rectum_077:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma, mucinous
  biomarker_profile: "KRAS G12D positive. MMR proficient."

rectum_078:
  morphology: NEUROENDOCRINE
  descriptive_name: Large cell neuroendocrine carcinoma of rectum
  biomarker_profile: "Molecular testing not indicated."

rectum_079:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "No mutations detected in hotspot panel."

rectum_080:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectosigmoid junction adenocarcinoma
  biomarker_profile: "NRAS mutation in codon 61 (Q61R). MSI-Low. All MMR proteins expressed."

rectum_081:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal tumor
  biomarker_profile: "RAS mutation present."

rectum_082:
  morphology: ADENOCARCINOMA
  descriptive_name: T3N1 moderately differentiated rectal adenocarcinoma
  biomarker_profile: "Guardant360 CDx: KRAS p.G12V detected at 8.2% cfDNA. TP53 p.R175H at 6.1%. No ERBB2 amplification."

rectum_083:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "All wild-type: KRAS, NRAS, BRAF. MSS. HER2 0."

rectum_084:
  morphology: CARCINOID
  descriptive_name: Rectal carcinoid tumor
  biomarker_profile: "Not tested."

rectum_085:
  morphology: ADENOCARCINOMA
  descriptive_name: Invasive rectal adenocarcinoma
  biomarker_profile: "MSI-High secondary to MLH1 hypermethylation. BRAF V600E positive. KRAS/NRAS wild-type."

rectum_086:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal CA, mod diff
  biomarker_profile: "KRAS exon 2 mutation detected."

rectum_087:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma with treatment effect
  biomarker_profile: "Post-treatment specimen: KRAS G13D persists. New TP53 mutation p.R273H. MSI-stable."

rectum_088:
  morphology: ADENOCARCINOMA
  descriptive_name: Lower third rectal adenocarcinoma
  biomarker_profile: "Caris MI Profile: No actionable mutations. TMB-Low (3 mut/Mb). MSI-stable. PD-L1 negative."

rectum_089:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal carcinoma
  biomarker_profile: "BRAF wild-type. MSI-stable."

rectum_090:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "HER2 positive (IHC 3+, FISH amplified with HER2/CEP17 ratio 5.2)."

rectum_091:
  morphology: NEUROENDOCRINE
  descriptive_name: Rectal neuroendocrine carcinoma
  biomarker_profile: "No molecular markers tested."

rectum_092:
  morphology: ADENOCARCINOMA
  descriptive_name: Locally advanced rectal adenocarcinoma
  biomarker_profile: "KRAS p.G12C mutation. TP53 p.P72R. MSI-stable. TMB 5 mut/Mb. PD-L1 TPS 2%."

rectum_093:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "Wild-type for KRAS/NRAS/BRAF."

rectum_094:
  morphology: ADENOCARCINOMA
  descriptive_name: Distal rectal carcinoma, stage IIIC
  biomarker_profile: "OncotypeDX: KRAS mutation detected. MSI-stable. TP53 mutant."

rectum_095:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal cancer
  biomarker_profile: "dMMR/MSI-H tumor with complete loss of PMS2 and focal loss of MLH1."

rectum_096:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma, well differentiated
  biomarker_profile: "KRAS A146V mutation. NRAS WT. BRAF WT. Microsatellite stable."

rectum_097:
  morphology: CARCINOID
  descriptive_name: Grade 2 rectal NET
  biomarker_profile: "Molecular testing not performed."

rectum_098:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma
  biomarker_profile: "Comprehensive panel all negative."

rectum_099:
  morphology: ADENOCARCINOMA
  descriptive_name: Mucinous adenocarcinoma of the rectum
  biomarker_profile: "MSI-H/dMMR with absent MSH2/MSH6. Germline MSH2 mutation c.1046C>G confirmed (Lynch syndrome). KRAS/NRAS/BRAF triple wild-type. TMB elevated at 38.5 mut/Mb. PD-L1 CPS 25."

rectum_100:
  morphology: ADENOCARCINOMA
  descriptive_name: Rectal adenocarcinoma, stage IIA
  biomarker_profile: "Standard biomarker panel: RAS wild-type (KRAS and NRAS), BRAF V600E negative, microsatellite stable, mismatch repair proficient."